
This study discusses the evidence for the involvement of specific members of the mycobiota in intestinal diseases, including inflammatory bowel disease, colorectal cancer and pancreatic cancer. It also highlights the importance of fungal interactions with intestinal bacteria and the immune system. The evidence highlights potential opportunities to target fungi and their interactions for therapeutic purposes.
Like
Save
Share